FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   Lotvin Alan 2. Date of Event Requiring Statement (Month/Day/Year) 06/04/2018 3. Issuer Name and Ticker or Trading Symbol CVS HEALTH Corp [CVS] (Last) (First) (Middle) ONE CVS DRIVE 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP, Transformation 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) WOONSOCKET, RI 02895 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 4,511.85 D   Common Stock 456.848 (1) I By Children's Trusts Common Stock (restricted) 450 (2) D   Common Stock (restricted) 6,027 (3) D   Common Stock (restricted) 2,933 (4) D   Common Stock (restricted) 966 (5) D   Common Stock (restricted) 1,427 (6) D   Common Stock (restricted) 3,339 (7) D   Common Stock (restricted) 3,843 (8) D   Stock Unit 8,142.8106 (9) D Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	04/01/2015(10)	04/01/2021	Common Stock	15,736	$ 74.29	D	Â
Stock Option	04/01/2016(11)	04/01/2022	Common Stock	21,386	$ 102.26	D	Â
Stock Option	04/01/2017(12)	04/01/2023	Common Stock	27,395	$ 104.82	D	Â
Stock Option	04/03/2018(13)	04/03/2024	Common Stock	32,911	$ 78.05	D	Â
Stock Option	04/01/2019(14)	04/01/2025	Common Stock	22,541	$ 62.21	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Lotvin Alan ONE CVS DRIVE WOONSOCKET, RI 02895	Â	Â	  EVP, Transformation	Â

Signatures

/s/ Alan M. Lotvin		06/08/2018
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Consists of shares held in UTMA Trusts for the benefit of the reporting person's children. The reporting person disclaims beneficial ownership of these shares.
(2)	Consists of remaining Restricted Stock Units awarded pursuant to Issuer's Performance-Based Restricted Stock Unit Plan, under its 2010 Incentive Compensation Plan. Restrictions lapse 2/28/2019.
(3)	Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse 4/1/2022.
(4)	Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 4/1/2019.
(5)	Consists of remaining Restricted Stock Units awarded pursuant to Issuer's Performance-Based Restricted Stock Unit Plan, under its 2010 Incentive Compensation Plan. Restrictions lapse in two equal installments on 2/28/2019 and 2/28/2020.
(6)	Consists of remaining Restricted Stock Units awarded pursuant to Issuer's Performance-Based Restricted Stock Unit Plan, under its 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 2/28/2019.
(7)	Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 4/1/2020.
(8)	Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 4/3/2021.
(9)	Consists of Stock Units awarded pursuant to Issuer's 2010 and 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer.
(10)	Remaining options became exercisable in four equal annual installments beginning on 4/1/2015.
(11)	Option became exercisable in four equal annual installments beginning on 4/1/2016.
(12)	Option became exercisable in four equal annual installments beginning on 4/1/2017.
(13)	Option became exercisable in four equal annual installments beginning on 4/3/2018.
(14)	Option becomes exercisable in four equal annual installments, commencing 4/1/2019.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.